Coldstream Capital Management Inc. decreased its holdings in shares of Hamilton Lane Incorporated (NASDAQ:HLNE – Free Report) by 3.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,657 shares of the company’s stock after selling 108 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Hamilton Lane were worth $449,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in HLNE. Cetera Advisors LLC acquired a new position in Hamilton Lane during the first quarter worth approximately $245,000. Fifth Third Bancorp increased its holdings in shares of Hamilton Lane by 106.5% during the 2nd quarter. Fifth Third Bancorp now owns 694 shares of the company’s stock worth $86,000 after buying an additional 358 shares during the last quarter. Argent Capital Management LLC raised its position in shares of Hamilton Lane by 50.8% in the 2nd quarter. Argent Capital Management LLC now owns 7,963 shares of the company’s stock worth $984,000 after buying an additional 2,684 shares during the period. EFG Asset Management North America Corp. raised its position in shares of Hamilton Lane by 0.5% in the 2nd quarter. EFG Asset Management North America Corp. now owns 17,185 shares of the company’s stock worth $2,125,000 after buying an additional 81 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in Hamilton Lane by 6.3% in the second quarter. Bank of New York Mellon Corp now owns 239,623 shares of the company’s stock valued at $29,613,000 after acquiring an additional 14,214 shares during the last quarter. Hedge funds and other institutional investors own 97.40% of the company’s stock.
Hamilton Lane Stock Performance
Hamilton Lane stock opened at $169.24 on Friday. Hamilton Lane Incorporated has a 12-month low of $103.42 and a 12-month high of $203.72. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.37 and a quick ratio of 3.37. The company has a market capitalization of $9.38 billion, a price-to-earnings ratio of 36.71 and a beta of 1.19. The firm’s fifty day moving average price is $184.59 and its 200 day moving average price is $155.35.
Hamilton Lane Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 7th. Stockholders of record on Monday, December 16th will be paid a dividend of $0.49 per share. This represents a $1.96 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Monday, December 16th. Hamilton Lane’s dividend payout ratio (DPR) is currently 42.52%.
Analyst Ratings Changes
HLNE has been the topic of a number of research reports. Keefe, Bruyette & Woods raised their price objective on Hamilton Lane from $181.00 to $215.00 and gave the stock a “market perform” rating in a report on Thursday, November 7th. UBS Group lifted their price target on shares of Hamilton Lane from $150.00 to $185.00 and gave the company a “neutral” rating in a research report on Tuesday, October 22nd. JPMorgan Chase & Co. increased their price objective on shares of Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Wells Fargo & Company lifted their target price on shares of Hamilton Lane from $189.00 to $194.00 and gave the company an “equal weight” rating in a report on Thursday. Finally, Morgan Stanley increased their price target on Hamilton Lane from $182.00 to $190.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Seven research analysts have rated the stock with a hold rating, According to data from MarketBeat, Hamilton Lane presently has a consensus rating of “Hold” and an average target price of $184.33.
View Our Latest Analysis on Hamilton Lane
Hamilton Lane Company Profile
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Stories
- Five stocks we like better than Hamilton Lane
- Insider Trades May Not Tell You What You Think
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Earnings Per Share Calculator: How to Calculate EPS
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.